Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (42)

« Back to Publications

Cognition and future depression: associations with risk in those with and without a history of depression.

de Cates AN. et al, (2026), BMJ Ment Health, 29

Women at the heart of mental science: commentary, Pinto da Costa et al.

Pinto da Costa M. et al, (2026), Br J Psychiatry, 228, 484 - 486

Authors response to nitrous oxide and mood: metabolic mechanisms (E. H. Reynolds).

Gill K. et al, (2026), EBioMedicine, 125

Nitrous oxide for the treatment of depression: a systematic review and meta-analysis.

Gill K. et al, (2025), EBioMedicine, 122

Cognition and Future Depression: Associations with Risk in Those With and Without a History of Depression

de Cates AN. et al, (2025)

Side effect profile and comparative tolerability of newer generation antidepressants in the acute treatment of major depressive disorder in children and adolescents: protocol for a systematic review and network meta-analysis.

Türkmen C. et al, (2025), BMJ Open, 15

Systematic Review and Meta-Analysis: The Association Between Newer-Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder.

Türkmen C. et al, (2025), J Am Acad Child Adolesc Psychiatry, 64, 1148 - 1164

The value of mental science: we publish what matters.

Malhi GS. et al, (2025), Br J Psychiatry, 227, 429 - 433

Underlying biological mechanisms of emotion dysregulation in bipolar disorder.

Durdurak BB. et al, (2025), Front Psychiatry, 16

TRANSLATING 5-HT4R AGONISM INTO MENTAL ILLNESS: POTENTIAL CLINICAL APPLICATIONS FOR MOOD DISORDER AND COGNITIVE IMPAIRMENT

de Cates A. et al, (2025), INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, i71 - i71

5-HT4 Receptor Agonists Are a Promising New Approach for the Treatment of Depression

Murphy S. et al, (2025), BIOLOGICAL PSYCHIATRY, 97

Neural Effects of a Novel 5HT4 Agonist in Major Depressive Disorder During an Emotional Faces Task

Gillespie A. et al, (2025), BIOLOGICAL PSYCHIATRY, 97

Early effects of a novel 5-HT4 agonist (PF-04995274) and the SSRI citalopram on emotional cognition in unmedicated depression: the RESTAND study

Gillespie A. et al, (2025)

Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial.

de Cates AN. et al, (2024), Br J Psychiatry, 225, 371 - 378

Author Correction: Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease.

Agarwal A. et al, (2024), Nat Med, 30

Load More